Halozyme Therapeutics, Inc. (HALO)

71.76 +1.33 (+1.89%) USD  |  NASDAQ  |  Jan 21, 12:28
More

Halozyme Therapeutics Preferred Stock (Quarterly)

Preferred Stock (Quarterly) Chart

View Preferred Stock (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock (Quarterly) Range, Past 5 Years

View Preferred Stock (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock (Quarterly) Benchmarks

View Preferred Stock (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade
Skye Bioscience, Inc. Upgrade